KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Emergent BioSolutions (EBS) Amortization - Deferred Charges (2016 - 2017)

Emergent BioSolutions has reported Amortization - Deferred Charges over the past 3 years, most recently at $95000.0 for Q4 2017.

  • For Q4 2017, Amortization - Deferred Charges fell 55.19% year-over-year to $95000.0; the TTM value through Dec 2017 reached $680000.0, up 11.48%, while the annual FY2017 figure was $681000.0, 12.8% down from the prior year.
  • Amortization - Deferred Charges for Q4 2017 was $95000.0 at Emergent BioSolutions, down from $195000.0 in the prior quarter.
  • Over five years, Amortization - Deferred Charges peaked at $215000.0 in Q3 2015 and troughed at $95000.0 in Q4 2017.
  • A 3-year average of $189111.1 and a median of $195000.0 in 2017 define the central range for Amortization - Deferred Charges.
  • Biggest five-year swings in Amortization - Deferred Charges: increased 7.61% in 2016 and later plummeted 55.19% in 2017.
  • Year by year, Amortization - Deferred Charges stood at $197000.0 in 2015, then rose by 7.61% to $212000.0 in 2016, then tumbled by 55.19% to $95000.0 in 2017.
  • Business Quant data shows Amortization - Deferred Charges for EBS at $95000.0 in Q4 2017, $195000.0 in Q3 2017, and $195000.0 in Q2 2017.